Search

everythinglearnresearchcommunity

for

Search:↓

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

The T-zone on the face has more androgen receptors and produces more oil than the U-zone.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Dutasteride and finasteride affect different cell types differently.

The method effectively measures drug impact on DHT levels in prostate treatments.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Male pattern baldness is linked to specific genetic variations in the androgen receptor gene.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

Androgens cause oil-producing skin cells with androgen receptors to mature and produce more oil.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Women with acne have lower levels of a specific hormone marker than women without acne.

Serum biomarkers like insulin-like growth factor-1 and vitamin D may help diagnose androgenetic alopecia.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

The hHa7 gene is regulated by androgens in certain body hair, not scalp hair.